The official launch of the Coalition For Accelerating Standards and Therapies (CFAST) reveals how far FDA is from achieving its goal of setting standards for clinical data in 57 therapeutic areas in five years.
Originally dubbed “55n5” when the goal was announced last December by CDER Director Janet Woodcock, the idea was to develop efficacy measurement standards for clinical trials in 55 diseases and...